THE GAP WE CLOSE

The standard we carry forward

Affordable for Kirehe. Acceptable anywhere else.

Our work begins in East Africa without being confined by it. We design for real constraints and global scrutiny at the same time, because women should not have to choose between what they can reach and what they can trust.

30.7%

of women aged 15–49 globally were living with anaemia in 2023.

16–91%

is the reported prevalence range for dysmenorrhoea across studies.

17 trials

studied perineal techniques in nearly 13,700 women—yet key outcomes remain under-reported.

2 hours

is the WHO-recommended early-treatment window for eligible intubated preterm newborns with RDS.

We started with one injury women were told to accept.

feature icon

01 A delivery room question

The journey began with a reality hiding in plain sight: preventable perineal injury was treated as the ordinary price of vaginal birth. Listening to women and midwives made it impossible to look away.

feature icon

02 A name that became a standard

Sawazisha means to equalise—to make fair. It became both our company name and our test for every design decision: does this bring good care closer, or create another layer of distance?

feature icon

03 One problem revealed a pattern

Waridi taught us that women’s health burdens are often not invisible. They are visible and normalised. Zawadi, WarmEase and our vaginal formulation platform each follow that same pattern into a different part of the lifecycle.

feature icon

04 Then listening led to the baby

SawaSurf sits at the edge of our women-first portfolio for a reason. A newborn fighting for breath is also a woman meeting motherhood through fear. We could not say we build through the lifecycle and turn away.

feature icon

05 From devices to capability

Today the work is larger than one product. We are building the scientific, clinical, regulatory and manufacturing capability required to move neglected burdens from recognition to care.